Midwest Professional Planners, Ltd. Biogen Inc. Transaction History

Midwest Professional Planners, Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $287,673 - $322,653	-1,323 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $5,262 - $5,801	-24 Reduced 1.78%	1,323 $309,000
Q1 2019 May 08, 2019	BUY	$216.71 - $338.96 $5,851 - $9,151	27 Added 2.05%	1,347 $318,000
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $11,975 - $15,168	-43 Reduced 3.15%	1,320 $397,000
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $324,035 - $423,748	1,104 Added 426.25%	1,363 $482,000
Q2 2018 Aug 10, 2018	SELL	$257.52 - $306.91 $3,605 - $4,296	-14 Reduced 5.13%	259 $75,000
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $48,904 - $69,167	188 Added 221.18%	273 $75,000
Q4 2017 Feb 13, 2018	BUY	$307.64 - $344.58 $26,149 - $29,289	85	85 $27,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Midwest Professional Planners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Midwest Professional Planners, Ltd. with notifications on news.